Literature DB >> 29194089

Quetiapine Dose Adjustments in Pregnant and Postpartum Women With Bipolar Disorder.

Emily A Pinheiro1, Katherine L Wisner, Crystal T Clark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29194089      PMCID： PMC5734989          DOI： 10.1097/JCP.0000000000000820

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  17 in total

Review 1.  Use of psychotropic drugs during pregnancy and breast-feeding.

Authors:  E R Larsen; P Damkier; L H Pedersen; J Fenger-Gron; R L Mikkelsen; R E Nielsen; V J Linde; H E D Knudsen; L Skaarup; P Videbech
Journal:  Acta Psychiatr Scand Suppl       Date:  2015

2.  Review of calls to an Australian teratogen information service regarding psychotropic medications over a 12-year period.

Authors:  Debra Kennedy; Maya Eamus; Majella Hill; Ju Lee Oei
Journal:  Aust N Z J Obstet Gynaecol       Date:  2013-09-13       Impact factor: 2.100

3.  Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum.

Authors:  Claudia M Klier; Nilufar Mossaheb; Alois Saria; Monika Schloegelhofer; Gerald Zernig
Journal:  J Clin Psychopharmacol       Date:  2007-12       Impact factor: 3.153

Review 4.  Gender-related differences in pharmacokinetics and their clinical significance.

Authors:  E Tanaka
Journal:  J Clin Pharm Ther       Date:  1999-10       Impact factor: 2.512

5.  Disposition of chiral and racemic fluoxetine and norfluoxetine across childbearing.

Authors:  Dorothy Sit; James M Perel; James F Luther; Stephen R Wisniewski; Joseph C Helsel; Katherine L Wisner
Journal:  J Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.153

6.  Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.

Authors:  Sengwee Toh; Qian Li; T Craig Cheetham; William O Cooper; Robert L Davis; Sascha Dublin; Tarek A Hammad; De-Kun Li; Pamala A Pawloski; Simone P Pinheiro; Marsha A Raebel; Pamela E Scott; David H Smith; William V Bobo; Jean M Lawrence; Inna Dashevsky; Katherine Haffenreffer; Lyndsay A Avalos; Susan E Andrade
Journal:  Arch Womens Ment Health       Date:  2013-02-07       Impact factor: 3.633

Review 7.  Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.

Authors:  Kristina M Deligiannidis; Nancy Byatt; Marlene P Freeman
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

8.  Lamotrigine dosing for pregnant patients with bipolar disorder.

Authors:  Crystal T Clark; Autumn M Klein; James M Perel; Joseph Helsel; Katherine L Wisner
Journal:  Am J Psychiatry       Date:  2013-11       Impact factor: 18.112

Review 9.  Clinical pharmacokinetics of quetiapine: an atypical antipsychotic.

Authors:  C L DeVane; C B Nemeroff
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

10.  Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review).

Authors:  Márcio G Soeiro-DE-Souza; Vasco Videira Dias; Giovanni Missio; Vicent Balanzá-Martinez; Leandro Valiengo; André F Carvalho; Ricardo Alberto Moreno
Journal:  Exp Ther Med       Date:  2015-01-23       Impact factor: 2.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.